Table 4.
Treatments | Drug costs (USD) | HRU costs (USD) | AE costs (USD) |
---|---|---|---|
IO Agents | |||
Avelumab | 12,894 | 696 | 375 |
Pembrolizumab | 12,953 | 464 | 67 |
Nivolumab | 13,034 | 348 | 67 |
Chemotherapy | |||
Carboplatin | 39 | 331 | 433 |
Carboplatin+etoposide | 152 | 766 | 1,334 |
Cyclophosphamide+doxorubicin+vincristine | 1,173 | 442 | 886 |
Topotecan | 207 | 1,214 | 3,287 |
Abbreviations: HRU, health care resource utilization; IO, immuno-oncology; AE, adverse event.